While senior government officials claimed that Johnson & Johnson (J&J) had agreed, in-principle, to pay compensation to the patients affected by its faulty hip implants, the company maintained it had the global expertise to arrive at a compensation mechanism on a case-to-case basis for each patient.
The government has fixed a minimum compensation amount of Rs 2 million for each affected patient, but J&J wants to arrive at a ‘mutually agreeable’ figure that need not be the same as the government has recommended.
Meanwhile, J&J has also claimed that it has reached out to almost 50 per cent of patients, who had

)